1William E P.Fundamental immunology[M].4th ed.New York:Lippincott Raven,1998:1387-1427.
2Cooper P D,McComb C,Steele E J.The adjuvanticity of Algammulin,a new vaccine adjuvant[J].Vaccine,1991;9(6):408-415.
3Siskind G W,Dunn P,Walker J G.Studies on the control of antibody synthesis(Ⅱ):Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized[J].J Exp Med,1968;127(1):55-56.
4Herbert W J.Mineral-oil adjuvants and the immunization of laboratory animals[M].In:Weir D M.Handbook of Experimental Immunology.3rd edition.Oxford:Blackwell Scientific Publications,2003:A3.1-A3.15.
5Hu J G,Kitagawa T.Studies on the optimal immunization schedule of experimental animals(Ⅵ):Antigen dose-response of aluminum hydroxide-aided immunization and booster effect under low antigen dose[J].Chem Pharm Bull,1990;38(10):2775-2779.
7Anthony C A,Noelene E B.Immunological adjuvants:desirable properties and side-effects[J].Mol Immunol,1991;28(3):279-284.
8Gupta R K,Rost B E,Relyveld E et al.Adjuvant properties of aluminum and calcium compounds[M].In:Powell M F,Newman M J.Vaccine Design:The subunit and adjuvant approach(Eds).New York:Plenum Publishing Corporation,1995:229-248.
9Cox J,Coulter A R.Adjuvantsa classification and review of their modes of action[J].Vaccine,1997;15(1):1-10.
10Singh M,Srivastava I.Advances in vaccine adjuvants for infectious diseases[J].Curr HIV Res,2003;1(3):309-320.
